Journal Club 2015.08.28.

Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs

ncomms8864

Vemuri B. Reddy1,*, Shuohao Sun2,*, Ehsan Azimi1, Sarina B. Elmariah1, Xinzhong Dong2 & Ethan A. Lerner1
Sensory neurons expressing Mas-related G-protein-coupled receptors (Mrgprs) mediate histamine-independent itch. We show that the cysteine protease cathepsin S activates MrgprC11 and evokes receptor-dependent scratching in mice. In contrast to its activation of conventional protease-activated receptors, cathepsin S-mediated activation of MrgprC11 did not involve the generation of a tethered ligand. We demonstrate further that different cysteine proteases selectively activate specific mouse and human Mrgpr family members. This expansion of our understanding by which proteases interact with G-protein-coupled receptors (GPCRs) redefines the concept of what constitutes a protease-activated receptor. The findings also implicate proteases as ligands to members of this orphan receptor family while providing new insights into how cysteine proteases contribute to itch.

Journal Club 2015.08.28. Read More »

Journal Club 2015.08.21

Role of PAR2 in regulating oxaliplatin-induced neuropathic pain via TRPA1

Abstract

Oxaliplatin (OXL) is a third-generation chemotherapeutic agent commonly used to treat metastatic digestive tumors; however, one of the main limiting complications of OXL is neuropathic pain. In this study, the underlying mechanisms responsible for OXL evoked-neuropathic pain were examined. Using a rat model, the results demonstrated that intraperitoneal (i.p.) injection of OXL significantly increased mechanical pain and cold sensitivity as compared with control animals (P < 0.05 vs. control rats). Blocking proteinase-activated receptor 2 (PAR2) significantly attenuated mechanical pain and cold sensitivity observed in control rats and OXL rats (P < 0.05 vs. vehicle control). The attenuating effect of PAR2 on mechanical pain and cold sensitivity were significantly smaller in OXL-rats than in control rats. The role played by PAR2 downstream signaling pathways [namely, transient receptor potential ankyrin 1 (TRPA1)] in regulating OXL evoked-neuropathic pain was also examined. The data shows that TRPA1 expression was upregulated in the lumbar dorsal root ganglion (DRG) of OXL rats and blocking TRPA1 inhibited mechanical pain and heightened cold sensitivity (P <0.05 vs. control rats). Blocking PAR2 also significantly decreased TRPA1expression in the DRG. Findings in this study show that OXL intervention amplifies mechanical hyperalgesia and cold hypersensitivity and PAR2 plays an important role in regulating OXLinduced neuropathic pain via TRPA1 pathways.

Blocking PAR2 attenuates oxaliplatin-induced neuropathic pain via TRPV1 and releases of substance P and CGRP in superficial dorsal horn of spinal cord

Abstract

Oxaliplatin (OXL) is a third-generation chemotherapeutic agent commonly used to treat metastatic digestive tumors; however, neuropathic pain is one of the main limiting complications of OXL. The purpose of this study was to examine the underlying mechanisms by which neuropathic pain is induced by OXL in a rat model. Our results demonstrated that blocking spinal proteinase-activated receptor 2 (PAR2) and transient receptor potential vanilloid 1 (TRPV1) attenuated pain responses evoked by mechanical stimulation and decreased the releases of substance P and CGRP in the superficial dorsal horn of the spinal cord. The attenuating effect on mechanical pain was significantly smaller in OXL-rats than that in control rats. Blocking PAR2 also attenuated a heightened cold sensitivity evoked by OXL; whereas blocking TRPV1 had little effects on OXL-evoked hypersensitive cold response. Our data also showed that OXL increased the protein expressions of PAR2 and TRPV1 in the superficial dorsal horn. In addition, blocking PAR2 decreased TRPV1 expression in OXL-rats. Overall, our data suggest that upregulated expression of PAR2 in the superficial dorsal horn contributes to mechanical hyperalgesia and cold hypersensitivity; whereas amplified TRPV1 plays a role in regulating mechanical hyperalgesia, but not cold hypersensitivity after administration of OXL. We further suggest that TRPV1 is likely one of the signaling pathways for PAR2 to play a role in regulating OXL-induced neuropathic pain.

Journal Club 2015.08.21 Read More »

Jouanal Club 2015.08.07

20150807_성민

 

Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice: role of blood cell-associated lysophospholipase D activity of autotaxin.

Abstract

Itching and infiltration of immune cells are important hallmarks of atopic dermatitis (AD). Although various studies have focused on peripheral mediator-mediated mechanisms, systemic mediator-mediated mechanisms are also important in the pathogenesis and development of AD. Herein, we found that intradermal injection of lysophosphatidic acid (LPA), a bioactive phospholipid, induces scratching responses by Institute of Cancer Research mice through LPA1 receptor- and opioid μ receptor-mediating mechanisms, indicating its potential as a pruritogen. The circulating level of LPA in Naruto Research Institute Otsuka Atrichia mice, a systemic AD model, with severe scratching was found to be higher than that of control BALB/c mice, probably because of the increased lysophospholipase D activity of autotaxin (ATX) in the blood (mainly membrane associated) rather than in plasma (soluble). Heparan sulfate proteoglycan was shown to be involved in the association of ATX with blood cells. The sequestration of ATX protein on the blood cells by heparan sulfate proteoglycan may accelerate the transport of LPA to the local apical surface of vascular endothelium with LPA receptors, promoting the hyperpermeability of venules and the pathological uptake of immune cells, aggravating lesion progression and itching in Naruto Research Institute Otsuka Atrichia mice.

Jouanal Club 2015.08.07 Read More »

Journal club 2015.07.24.

Polysulfide evokes acute pain through the activation of nociceptive TRPA1 in mouse sensory neurons
Yukari Hatakeyama1, Kenji Takahashi1, Makoto Tominaga2, Hideo Kimura3 and Toshio Ohta1*

s12990-015-0023-4

Abstract
Background: Hydrogen sulfide (H2S) is oxidized to polysulfide. Recent reports show that this sulfur compound modulates various biological functions. We have reported that H2S is involved in inflammatory pain in mice. On the other hand, little is known about the functional role of polysulfide in sensory neurons. Here we show that polysulfide selectively stimulates nociceptive TRPA1 and evokes acute pain, using TRPA1-gene deficient mice (TRPA1(−/−)), a heterologous expression system and a TRPA1-expressing cell line.
Results: In wild-type mouse sensory neurons, polysulfide elevated the intracellular Ca concentration ([Ca2+]i) in a dose-dependent manner. The half maximal effective concentration (EC50) of polysulfide was less than one-tenth that of H2S. The [Ca2+]i responses to polysulfide were observed in neurons responsive to TRPA1 agonist and were inhibited by blockers of TRPA1 but not of TRPV1. Polysulfide failed to evoke [Ca2+]i increases in neurons from TRPA1(−/−) mice. In RIN-14B cells, constitutively expressing rat TRPA1, polysulfide evoked [Ca2+]i increases with the same EC50 value as in sensory neurons. Heterologously expressed mouse TRPA1 was activated by polysulfide and that was suppressed by dithiothreitol. Analyses of the TRPA1 mutant channel revealed that cysteine residues located in the internal domain were related to the sensitivity to polysulfide. Intraplantar injection of polysulfide into the mouse hind paw induced acute pain and edema which were significantly less than in TRPA1(−/−) mice.
Conclusions: The present data suggest that polysulfide functions as pronociceptive substance through the activation of TRPA1 in sensory neurons. Since the potency of polysulfide is higher than parental H2S and this sulfur compound is generated under pathophysiological conditions, it is suggested that polysulfide acts as endogenous ligand for TRPA1. Therefore, TRPA1 may be a promising therapeutic target for endogenous sulfur compound-related algesic action.
Keywords: Transient Receptor Potential Channels (TRP Channels), Calcium imaging, Dorsal root ganglia, Heterologous expression

Journal club 2015.07.24. Read More »

Journal club 2015.07.17.

A Sensory Neuron-expressed Interleukin-31 Receptor Mediates T helper Cell-dependent Itch: Involvement of TRPV1 and TRPA1

nihms540721

Ferda Cevikbas, PhD1,5,*, Xidao Wang, PhD2,*, Tasuku Akiyama, PhD3, Cordula Kempkes, PhD1, Terhi Savinko, PhD4, Attila Antal, MD5, Gabriela Kukova, MD5, Timo Buhl, MD1, Akihiko Ikoma, MD, PhD1, Joerg Buddenkotte, PhD6, Vassili Soumelis, MD7, Micha Feld, PhD5, Harri Alenius, PhD4, Stacey R. Dillon, PhD8, Earl Carstens, PhD3, Bernhard Homey, MD5,#,§, Allan Basbaum, PhD2,#,§, and Martin Steinhoff, MD, PhD1,5,#,§
1Depts. of Dermatology and Surgery, University of California San Francisco, San Francisco, CA, USA 2Depts. of Anatomy and W.M. Keck Foundation Center for Integrative Neuroscience, University California San Francisco, San Francisco, CA, USA 3Dept. of Neurobiology, University California Davis, CA, USA 4Unit of Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland 5Dept. of Dermatology, University Hospital Duesseldorf, Duesseldorf, Germany 6Dept. of Dermatology, University Hospital Muenster, Muenster Germany 7Dep. of Immunology, Institut Curie, Paris, France 8ZymoGenetics, Inc. (a Bristol-Myers Squibb Company) Seattle, WA, USA

Abstract
Background—Although the cytokine, interleukin-31 (IL-31), has been implicated in
inflammatory and lymphoma-associated itch, the cellular basis for its pruritic action is yet unclear.
Objective—To determine whether immune cell-derived IL-31 directly stimulates sensory neurons, and to identify the molecular basis of IL-31-induced itch.
Methods—We used immunohistochemistry and qRTPCR to determine IL-31 expression levels in mice and humans. Immunohistochemistry, immunofluorescence, qRTPCR, in vivo pharmacology, western blotting, single cell calcium and electrophysiology were used to examine the distribution, functionality and cellular basis of the neuronal IL-31 receptor (IL-31RA) in mice and humans.
Results—Among all immune and resident skin cells examined, IL-31 was predominantly produced by TH2 and to a significantly lesser extend by mature dendritic cells. Cutaneous and intrathecal injections of IL-31 evoked intense itch, and its concentration increased significantly in murine atopic-like dermatitis skin. Both human and mouse DRG neurons express IL-31RA, largely in neurons that co-express TRPV1. IL-31-induced itch was significantly reduced in TRPV1- and TRPA1-deficient mice, not c-kit or PAR-2 mice. In cultured primary sensory neurons, IL-31 triggered Ca2+-release and ERK1/2 phosphorylation, Inhibition of which blocked IL-31 signaling in vitro and reduced IL-31-induced scratching in vivo.
Conclusion—IL-31RA is a functional receptor expressed by a small subpopulation of IL-31RA+/TRPV1+/TRPA1+ neurons, and is a critical neuro-immune link between TH2 cells and sensory nerves for the generation of T cell-mediated itch. Thus, targeting neuronal IL-31RA may be effective in the management of TH2-mediated itch, including atopic dermatitis and cutaneous T cell lymphoma.
Keywords
cytokine; atopic dermatitis; sensory nerve; skin; TRP channel

© 2013 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.
#Addresses for correspondence: Martin Steinhoff, M.D., Ph.D., Departments of Dermatology and Surgery, University of California, San Francisco, 513 Parnassus Ave, Room S-1268, San Francisco, CA, 94143 USA, Phone: +1 415 476 6978, FAX: +1 415 476 0936, SteinhoffM@derm.ucsf.edu. Allan. I. Basbaum, Ph.D., Department of Anatomy, University of California, San Francisco, 1550 4th Street, San Francisco, CA, USA, Phone: +1 415 476 5270, FAX: +1 415 476 1974, Allan.Basbaum@ucsf.edu. Bernhard Homey, M.D.. Department of Dermatology. University Hospital Duesseldorf, Duesseldorf, Germany, Phone: +49 211 811 7600, FAX: +49 211 811 7316, bernhard.homey@uni-duesseldorf.de.
*contributed equally to this work; §Co-senior authors;
Author contribution:
F. C.: conducted most of the experiments, designed the study, wrote manuscript. X. W.: conducted in vivo and morphological experiments with F.C. T.A: performed single cell calcium measurement and electrophysiology recordings under supervision of E.C; T. S.: designed the study for the in vivo mouse models of AD under supervision of H.A; A.A, M.F.: performed human staining experiments of skin tissue and qPCR of cells under supervision of B.H.; C. K.: performed western blotting and wrote part of the manuscript; G. K.: performed human staining experiments of skin tissue and qPCR of cells; A. I.: assisted in cheek model assay; T. B.: stained human DRG for IL-31RA; H. A.: supervised the murine AD study; S. D.: supervised vivo mouse studies; E. C.: supervised electrophysiology study; B. H.: designed, supervised human IL-31 studies and mouse atopy models, and wrote manuscript; A.I.B.: designed, supervised the neuronal experiments, and wrote manuscript; M.S.: designed, supervised all experiments, analyzed data, and wrote manuscript.
Publisher’s Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Journal club 2015.07.17. Read More »

Journal club 2015.07.10.

HTR7 Mediates Serotonergic Acute and Chronic Itch

HTR7 Mediates Serotonergic Acute and Chronic Itch

Takeshi Morita,1,2,7 Shannan P. McClain,1,7 Lyn M. Batia,1 Maurizio Pellegrino,1 Sarah R. Wilson,1,2 Michael A. Kienzler,3 Kyle Lyman,3 Anne Sofie Braun Olsen,3 Justin F. Wong,1 Cheryl L. Stucky,4 Rachel B. Brem,5,6,* and Diana M. Bautista1,2,* 1Department of Molecular & Cell Biology, 142 Life Sciences Addition, University of California, Berkeley, Berkeley, CA 94720-3200, USA 2Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA
3Neurobiology Course, Marine Biological Laboratory, Woods Hole, MA 02543, USA
4Departments of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA 5Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA
6Department of Plant and Microbial Biology, University of California, Berkeley, Berkeley, CA 94720, USA
7Co-first author
*Correspondence: rbrem@buckinstitute.org (R.B.B.), dbautista@berkeley.edu (D.M.B.) http://dx.doi.org/10.1016/j.neuron.2015.05.044

SUMMARY
Chronic itch is a prevalent and debilitating condition for which few effective therapies are available. We harnessed the natural variation across genetically distinct mouse strains to identify transcripts co-re- gulated with itch behavior. This survey led to the discovery of the serotonin receptor HTR7 as a key mediator of serotonergic itch. Activation of HTR7 promoted opening of the ion channel TRPA1, which in turn triggered itch behaviors. In addition, acute itch triggered by serotonin or a selective serotonin reuptake inhibitor required both HTR7 and TRPA1. Aberrant serotonin signaling has long been linked to a variety of human chronic itch conditions, in- cluding atopic dermatitis. In a mouse model of atopic dermatitis, mice lacking HTR7 or TRPA1 dis- played reduced scratching and skin lesion severity. These data highlight a role for HTR7 in acute and chronic itch and suggest that HTR7 antagonists may be useful for treating a variety of pathological itch conditions.

Journal club 2015.07.10. Read More »

Journal club 2015.7.3

Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing

Abstract

The primary sensory system requires the integrated function of multiple cell types, although its full complexity remains unclear. We used comprehensive transcriptome analysis of 622 single mouse neurons to classify them in an unbiased manner, independent of any a priori knowledge of sensory subtypes. Our results reveal eleven types: three distinct low-threshold mechanoreceptive neurons, two proprioceptive, and six principal types of thermosensitive, itch sensitive, type C low-threshold mechanosensitive and nociceptive neurons with markedly different molecular and operational properties. Confirming previously anticipated major neuronal types, our results also classify and provide markers for new, functionally distinct subtypes. For example, our results suggest that itching during inflammatory skin diseases such as atopic dermatitis is linked to a distinct itch-generating type. We demonstrate single-cell RNA-seq as an effective strategy for dissecting sensory responsive cells into distinct neuronal types. The resulting catalog illustrates the diversity of sensory types and the cellular complexity underlying somatic sensation.

Journal club 2015.7.3 Read More »

Journal club 2015.6.19

Tryptase and protease-activated receptor-2 stimulate scratching behavior in a murine model of ovalbumin-induced atopic-like dermatitis.

Abstract

The aim of the current study was to investigate the involvement of tryptase and protease-activated receptor-2 (PAR2) in the pathogenesis of itch using a recently developed murine model of atopic dermatitis (AD) elicited by epicutaneous sensitization with ovalbumin (OVA). We also examined whether tacrolimus exerts an antipruritic effect. Epicutaneous sensitization of BALB/c mice with OVA led to a significant increase in the number of scratches. Notably, PAR2 mRNA and protein levels as well as cutaneous levels of tryptase were significantly enhanced in epicutaneously sensitized mice. Pretreatment with the protease inhibitor, leupeptin, PAR2 antibody, and tacrolimus significantly reduced the number of degranulated mast cells and tryptase content, and consequently alleviated scratching behavior. Cetirizine (10mg/kg) exerted a significant inhibitory effect on the scratching behavior of mice, but did not affect the number of degranulated mast cells and induction of tryptase. Our results collectively suggest that tryptase and PAR2 are involved in OVA allergy-induced scratching behavior.

Journal club 2015.6.19 Read More »

Journal Club 2015.06.12.

RESEARCH ARTICLE

Five hTRPA1 Agonists Found in Indigenous Korean Mint, Agastache rugosa

journal.pone.0127060

Hana Moon1☯, Min Jung Kim1☯, Hee Jin Son1, Hae-Jin Kweon2, Jung Tae Kim1, Yiseul Kim1, Jaewon Shim1, Byung-Chang Suh2, Mee-Ra Rhyu1*
1 Research Group of Food Functionality, Korea Food Research Institute, Bundang-gu, Sungnam-si, Gyeonggi-do, Republic of Korea, 2 Department of Brain Science, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea
☯ These authors contributed equally to this work. * mrrhyu@kfri.re.kr

Abstract
Transient receptor potential ankyrin1 (TRPA1) and transient receptor potential vanilloid 1 (TRPV1) are members of the TRP superfamily of structurally related, nonselective cation channels and mediators of several signaling pathways. Previously, we identified methyl syr- ingate as an hTRPA1 agonist with efficacy against gastric emptying. The aim of this study was to find hTRPA1 and/or hTRPV1 activators in Agastache rugosa (Fisch. et Meyer) O. Kuntze (A.rugosa), commonly known as Korean mint to improve hTRPA1-related phenome- na. An extract of the stem and leaves of A.rugosa (Labiatae) selectively activated hTRPA1 and hTRPV1. We next investigated the effects of commercially available compounds found in A.rugosa (acacetin, 4-allylanisole, p-anisaldehyde, apigenin 7-glucoside, L-carveol, β- caryophyllene, trans-p-methoxycinnamaldehyde, methyl eugenol, pachypodol, and ros- marinic acid) on cultured hTRPA1- and hTRPV1-expressing cells. Of the ten compounds, L-carveol, trans-p-methoxycinnamaldehyde, methyl eugenol, 4-allylanisole, and p-anisal- dehyde selectively activated hTRPA1, with EC50 values of 189.1±26.8, 29.8±14.9, 160.2 ±21.9, 1535±315.7, and 546.5±73.0 μM, respectively. The activities of these compounds were effectively inhibited by the hTRPA1 antagonists, ruthenium red and HC-030031. Al- though the five active compounds showed weaker calcium responses than allyl isothiocya- nate (EC50=7.2±1.4 μM), our results suggest that these compounds from the stem and leaves of A.rugosa are specific and selective agonists of hTRPA1.

Journal Club 2015.06.12. Read More »

Journal Club 2015.6.5

Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation.

Abstract

Oxaliplatin is a platinum-based anticancer drug used to treat metastatic colorectal, breast, and lung cancers. While oxaliplatin kills cancer cells effectively, it exhibits several side effects of varying severity. Neuropathic pain is commonly experienced during treatment with oxaliplatin. Patients describe symptoms of paresthesias or dysesthesias that are triggered by cold (acute neuropathy), or as abnormal sensory or motor function (chronic neuropathy). In particular, we found that aluminum levels were relatively high in some cancer patients suffering from neuropathic pain based on clinical observations. Based on these findings, we hypothesized that aluminum accumulation in the dorsal root ganglion (DRG) in the course of oxaliplatin treatment exacerbates neuropathic pain. In mice injected with oxaliplatin (three cycles of 3 mg/kg i.p. daily for 5 days, followed by 5 days of rest), we detected cold allodynia using the acetone test, but not heat hyperalgesia using a hot plate. However, co-treatment with aluminum chloride (AlCl3∙6H2O; 7 mg/kg i.p. for 14 days: equivalent 0.78 mg/kg of elemental Al) and oxaliplatin (1 cycle of 3 mg/kg i.p. daily for 5 days, followed by 5 days of rest) synergistically induced cold allodynia as well as increased TRPAl mRNA and protein expression. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) analysis showed a significant increase in aluminum concentrations in the DRG of mice treated with aluminum chloride and oxaliplatin compared to aluminum chloride alone. Similarly, in a mouse induced-tumor model, aluminum concentrations were increased in DRG tissue and tumor cells after oxaliplatin treatment. Taken together, these findings suggest that aluminum accumulation in the DRG may exacerbate neuropathic pain in oxaliplatin-treated mice.

Journal Club 2015.6.5 Read More »

Scroll to Top